Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment strategies for clear cell renal cell carcinoma: Past, present and future
Junwei Yang, Kuansong Wang, Zhichun Yang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies
Valentina Schiavoni, Roberto Campagna, Valentina Pozzi, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3207-3207
Open Access | Times Cited: 32
Characterization of a G2M checkpoint-related gene model and subtypes associated with immunotherapy response for clear cell renal cell carcinoma
Zhenwei Wang, Zongtai Zheng, Bangqi Wang, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e29289-e29289
Open Access | Times Cited: 6
Targeting apoptosis in clear cell renal cell carcinoma
Adam Kowalewski, Jędrzej Borowczak, Mateusz Maniewski, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116805-116805
Open Access | Times Cited: 5
Emerging Horizons in Renal Cell Carcinoma Therapy: Impact of Cuproptosis-Related miRNAs on RCC
Subeka Abraham Gnanadass, Pragasam Viswanathan
Lecture notes in electrical engineering (2025), pp. 44-53
Closed Access
Differentiating between renal medullary and clear cell renal carcinoma with a machine learning radiomics approach
Rahim Jiwani, Koustav Pal, Iwan Paolucci, et al.
The Oncologist (2025) Vol. 30, Iss. 2
Open Access
Liposomal Tubacin: Strategies for the Formulation of a Highly Hydrophobic Anticancer Drug
Cindy Schelker, Léa Revaclier, Gerrit Borchard, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 491-491
Open Access
Targeting apoptosis and unfolded protein response: the impact of β-hydroxybutyrate in clear cell renal cell carcinoma under glucose-deprived conditions
Fatemeh Roohy, Morvarid Siri, Kiarash Kohansal, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 4
Trend of cardiovascular mortality among metastatic renal cell cancer patients in the US from 2005 to 2020
Nischit Baral, Elena Deych, Deepak Chandramohan, et al.
Cancer Epidemiology (2025) Vol. 95, pp. 102758-102758
Closed Access
Cuproptosis Regulation by Long Noncoding RNAs: Mechanistic Insights and Clinical Implications in Cancer
Nahla E. El‐Ashmawy, Eman G. Khedr, Mariam A. Abo-Saif, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110324-110324
Closed Access
Exosome-derived hsa-miR-200c-3p, hsa-miR-25-3p and hsa-miR-301a-3p as potential biomarkers and therapeutic targets for restoration of PTEN expression in clear cell renal cell carcinoma
Andreia P Alves, Mariana Ferreira, Mariana Eiras, et al.
International Journal of Biological Macromolecules (2025), pp. 140607-140607
Closed Access
NIPAL4 is an important marker for clear cell renal cell carcinoma prognosis and immunotherapy
Shuyan Wei, Fang Lyu, Bei Qian, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Relevance of Platelet-lymphocyte Ratio in Tumor Characteristics and Survival in Clear Cell-renal Cell Carcinoma
Santhosh Srinivasan, Poulose Chally, Abiodun Luqman Azeez, et al.
Current Medical Issues (2025) Vol. 23, Iss. 2, pp. 87-91
Open Access
Molecular landscape of clear cell renal cell carcinoma: targeting the Wnt/β-catenin signaling pathway
Judyta Górka, Katarzyna Miękus
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma
Zhiduan Cai, Wenjun Luo, Haoran Wang, et al.
Cancer Science (2024) Vol. 115, Iss. 6, pp. 1791-1807
Open Access | Times Cited: 3
The role of RNA-modifying proteins in renal cell carcinoma
Muna A. Ali, Khuloud Bajbouj, Iman M. Talaat, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 3
Immunotherapy of Clear-Cell Renal-Cell Carcinoma
Sophie Grigolo, Luis Filgueira
Cancers (2024) Vol. 16, Iss. 11, pp. 2092-2092
Open Access | Times Cited: 3
PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer
Norman Fultang, Ashley M. Schwab, Sophia McAneny-Droz, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
The Pancreas as a Target of Metastasis from Renal Cell Carcinoma: Is Surgery Feasible and Safe? A Single-Center Experience in a High-Volume and Certified Pancreatic Surgery Center in Germany
Sara Al-Madhi, Sara Acciuffi, Frank Meyer, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1921-1921
Open Access | Times Cited: 2
Knockdown of Antisense Noncoding Mitochondrial RNA Reduces Tumorigenicity of Patient-Derived Clear Cell Renal Carcinoma Cells in an Orthotopic Xenograft Mouse Model
Mariela Araya, Francisca Sepúlveda, Jaime Villegas, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 830-830
Open Access | Times Cited: 1
Niraparib for the treatment of metastatic ccRCC in a patient with CDK12 and RAD51C mutations: a case report
Xiaolong Yue, Chenkang Yang, Dandan Cao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Decoding PTEN regulation in clear cell renal cell carcinoma: Pathway for biomarker discovery and therapeutic insights
Ângela Alves, Rui Medeiros, Ana Luísa Teixeira, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189165-189165
Open Access | Times Cited: 1
Approach to Late Noninfectious Post-Transplant Complications
Sami Alasfar, Hay Me Me, Pooja Budhiraja
Advances in Kidney Disease and Health (2024) Vol. 31, Iss. 5, pp. 436-449
Closed Access | Times Cited: 1
Effects of Purine Metabolism-Related LINC01671 on Tumor Heterogeneity in Kidney Renal Clear Cell Carcinoma
Wei Yin, Jinhua Wang, Yumei Liang, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 12, pp. 354-354
Open Access | Times Cited: 2
Combination of PARP and DNA methylation inhibitors as a potential personalized therapy for SETD2-mutated clear-cell renal cancers
Ali Shahini, Yasser Riazalhosseini
Translational Andrology and Urology (2024) Vol. 13, Iss. 7, pp. 1315-1318
Open Access
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update
Andrey Soares, Fernando Sabino Marques Monteiro, Karine Martins da Trindade, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access
Page 1 - Next Page

Scroll to top